Saint John Regional Hospital Tumour Bank / Atlantic Canada Biobanking Consortium, Canada

Certification Status: Approved

Registration Status: Completed

Objective: The Saint John Regional Hospital Tumour Bank (SJRHTB) is an initiative to collect and store specimens and clinical information for use in future research. Researchers can request to access these de-identified and coded specimens and clinical information to facilitate research and potentially lead to better testing and/or treatments for cancer. Researchers must have a Research Ethics Board (REB) approved study protocol and complete the Saint John Regional Hospital Specimen Retrieval application and Material Transfer Agreement prior to accessing samples from the SJRHTB and will only receive de-identified information and samples.

Registered Biobank Name	Saint John Regional Hospital Tumour Bank / Atlantic Canada Biobanking Consortium
Biobank Leader	Nicholas J Lignos
Country	Canada
Email for biobank inquiries	Nicholas.Lignos@HorizonNB.ca
Principal Investigator	Dr. Behram Cenk Acar
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).